Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery

Completed · Phase 3

Conditions studied: Cataract

In brief

The purpose of this study is to compare the effectiveness of Nepafenac Ophthalmic Suspension, 0.1% eye drops to Acular LS eye drops, used before and after cataract surgery, for treating inflammation in the eye.

Key facts

Study ID

NCT00333255

Run by

Alcon Research

People needed

267

Starts

2005-09-01

Last updated by the study team

2009-07-08

Who can join

Age: 10 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• planned cataract extraction with posterior chamber intraocular lens implantation

You may not qualify if…

• Under 10

Where it is running

• Lehmann Eye Center — Nacogdoches, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.